Molecular Partners Balance Sheet Health
Financial Health criteria checks 6/6
Molecular Partners has a total shareholder equity of CHF155.6M and total debt of CHF0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CHF170.6M and CHF15.0M respectively.
Key information
0%
Debt to equity ratio
CHF 0
Debt
| Interest coverage ratio | n/a |
| Cash | CHF 159.13m |
| Equity | CHF 155.57m |
| Total liabilities | CHF 15.05m |
| Total assets | CHF 170.62m |
Recent financial health updates
Is Molecular Partners (VTX:MOLN) In A Good Position To Invest In Growth?
Jan 09
Here's Why We're Watching Molecular Partners' (VTX:MOLN) Cash Burn Situation
Sep 08Molecular Partners (VTX:MOLN) Is In A Good Position To Deliver On Growth Plans
May 09We're Hopeful That Molecular Partners (VTX:MOLN) Will Use Its Cash Wisely
Jun 24Molecular Partners (VTX:MOLN) Is In A Good Position To Deliver On Growth Plans
Jan 21Recent updates
We Think Some Shareholders May Hesitate To Increase Molecular Partners AG's (VTX:MOLN) CEO Compensation
Apr 11Is Molecular Partners (VTX:MOLN) In A Good Position To Invest In Growth?
Jan 09Here's Why We're Watching Molecular Partners' (VTX:MOLN) Cash Burn Situation
Sep 08Need To Know: The Consensus Just Cut Its Molecular Partners AG (VTX:MOLN) Estimates For 2023
Jun 23What You Need To Know About The Molecular Partners AG (VTX:MOLN) Analyst Downgrade Today
Aug 31Molecular Partners (VTX:MOLN) Is In A Good Position To Deliver On Growth Plans
May 09Upgrade: Analysts Just Made A Substantial Increase To Their Molecular Partners AG (VTX:MOLN) Forecasts
Dec 26We're Hopeful That Molecular Partners (VTX:MOLN) Will Use Its Cash Wisely
Jun 24Molecular Partners AG (VTX:MOLN) Could Be Less Than A Year Away From Profitability
Mar 09Analysts Just Made A Major Revision To Their Molecular Partners AG (VTX:MOLN) Revenue Forecasts
Feb 10Molecular Partners (VTX:MOLN) Is In A Good Position To Deliver On Growth Plans
Jan 21How Much Of Molecular Partners AG (VTX:MOLN) Do Insiders Own?
Dec 17
Downgrade: Here's How Analysts See Molecular Partners AG (VTX:MOLN) Performing In The Near Term
Nov 21Financial Position Analysis
Short Term Liabilities: MOLN's short term assets (CHF165.6M) exceed its short term liabilities (CHF11.4M).
Long Term Liabilities: MOLN's short term assets (CHF165.6M) exceed its long term liabilities (CHF3.7M).
Debt to Equity History and Analysis
Debt Level: MOLN is debt free.
Reducing Debt: MOLN had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MOLN has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: MOLN has sufficient cash runway for 2.1 years if free cash flow continues to grow at historical rates of 2.5% each year.